Advanced Health Intelligence (NASDAQ: AHI, ASX AHI) provides scalable health assessment, risk stratification, and digital triage to health care providers, insurers, employers, and governments.

Since being founded in Perth in 2014, AHI has been delivering health tech innovations using smartphones – starting with the first on-device body-dimensioning capability. Now, with global patents in all major markets, AHI brings forth the next frontier in digitizing health assessment with composable solutions.

AHI has assembled a leading team of medically trained professionals, AI, computer vision, and data scientists to develop the most comprehensive smartphone-based risk assessment tool currently available, culminating in:

‍

• Body dimension and composition assessment to identify the comorbidities of obesity, such as diabetes risk estimates.
• Blood biomarker prediction, including HbA1C, HDL, LDL, and 10-year mortality risk.
• Transdermal Optical Imaging (TOI) to return vital signs and, cardiovascular disease risk estimates.
• On-device dermatological skin identification with 588 skin conditions across 133 categories, including melanoma.
• Assisting partners in delivering personalized therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy. 

‍

With a focus on impact at scale, AHI is proud to showcase a milestone in digital health transformation – a biometrically-derived triage solution – all accessible on a smartphone. With these advanced technologies, AHI can help partners escalate patients into right-care pathways for proactive health management at the population scale.

This delivery of proprietary capabilities unlocks cost-effective health assessment for billions of smartphone users worldwide. In doing so, AHI endeavors to put the power of possibility into the hands of communities, empowering people to take control of their journey to better health. 

‍

This is ubiquitous proactive healthcare.